Free Trial

Danaher Corporation (NYSE:DHR) Shares Bought by Larson Financial Group LLC

Danaher logo with Medical background

Larson Financial Group LLC grew its position in Danaher Corporation (NYSE:DHR - Free Report) by 154.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,517 shares of the conglomerate's stock after buying an additional 3,346 shares during the period. Larson Financial Group LLC's holdings in Danaher were worth $1,131,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Heck Capital Advisors LLC purchased a new position in Danaher during the 4th quarter worth approximately $27,000. GHP Investment Advisors Inc. boosted its stake in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the last quarter. Sierra Ocean LLC boosted its stake in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the last quarter. Hurley Capital LLC acquired a new stake in Danaher during the 4th quarter worth $34,000. Finally, Smallwood Wealth Investment Management LLC acquired a new position in shares of Danaher during the 1st quarter valued at about $31,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president owned 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.

Wall Street Analyst Weigh In

DHR has been the topic of several recent research reports. Wells Fargo & Company lowered their price target on shares of Danaher from $240.00 to $210.00 and set an "equal weight" rating on the stock in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. cut their target price on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Argus lowered their price target on Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft decreased their price objective on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Finally, Barclays reiterated an "overweight" rating and issued a $225.00 price objective (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Three research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $248.48.

Read Our Latest Research Report on Danaher

Danaher Price Performance

Danaher stock traded down $4.81 during midday trading on Friday, reaching $189.98. 4,239,138 shares of the company were exchanged, compared to its average volume of 4,192,474. The company has a market capitalization of $135.96 billion, a price-to-earnings ratio of 36.89, a P/E/G ratio of 2.71 and a beta of 0.77. The firm's 50-day simple moving average is $196.12 and its 200-day simple moving average is $205.48. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. On average, analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.67%. Danaher's dividend payout ratio is currently 24.85%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines